Powered by
DETROIT—The Barbara Ann Karmanos Cancer Institute recently received a $352,437 grant from the U CAN-CER VIVE Foundation to help fund a pancreatic cancer research study. The outcomes of this study will help …
NOVI—Officials at Delphinus Medical Technologies Inc. announced that the U.S. Food and Drug Administration has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System. The system is …
DETROIT—The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) launched new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and …
DETROIT—Officials at the Barbara Ann Karmanos Cancer Institute announced that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025, making …
DETROIT—An oral therapy that has been studied in laboratory experiments and clinical trials at the Barbara Ann Karmanos Cancer Institute, in partnership with Karyopharm Therapeutics Inc., will soon enter clinical …